Page last updated: 2024-09-04

carbapenems and cefaclor anhydrous

carbapenems has been researched along with cefaclor anhydrous in 4 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(cefaclor anhydrous)
Trials
(cefaclor anhydrous)
Recent Studies (post-2010) (cefaclor anhydrous)
7,3551475,27791926092

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)cefaclor anhydrous (IC50)
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1Homo sapiens (human)7.184

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D1
Appelbaum, PC; Jacobs, MR; Spangler, SK1
Inoue, E; Mitsuhashi, S1
Verbist, L; Verhaegen, J1

Other Studies

4 other study(ies) available for carbapenems and cefaclor anhydrous

ArticleYear
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States

1995
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance

1994
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9

    Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefaclor; Cefixime; Cefmenoxime; Cefotaxime; Drug Stability; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Microbial Sensitivity Tests

1994
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae

1998